title: Ulcerative colitis in a patient with common variable immunodeficiency: does the treatment differ from the routine?
abstract: Common variable immunodeficiency (CVID) is associated with gastrointestinal manifestations, in particular diarrhea (1,2). It is linked to autoimmune disorders such as nodular lymphoid hyperplasia (NLH), possibly increasing the risk of lymphoma (3). The prevalence of chronic inflammatory bowel disease (CIBD) in these patients is increased, above all Crohn's disease (4,5) and its treatment does not seem to differ from the standard (2). We were presented with a patient with CVID and ulcerative colitis treated in the conventional manner.
authors.affiliation: Medicina Digestiva, Hospital de la Ribera de Alzira, España.
authors.forename: Carlos
authors.initials: C
authors.lastname: Alventosa Mateu
authors.affiliation: Medicina Digestiva, Hospital de la Ribera (Alzira), España.
authors.forename: Lucía
authors.initials: L
authors.lastname: Ruiz Sánchez
authors.affiliation: Medicina Digestiva, Hospital de la Ribera (Alzira), España.
authors.forename: Cirilo
authors.initials: C
authors.lastname: Amorós García
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use; D053704:Capsule Endoscopy; D003093:Colitis, Ulcerative / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D017074:Common Variable Immunodeficiency / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D020518:Focal Nodular Hyperplasia / Q000000981:diagnostic imaging; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D039841:Leukocyte L1 Antigen Complex / Q000097:blood; D008297:Male; D008875:Middle Aged
chemical_list: D007166:Immunosuppressive Agents; D039841:Leukocyte L1 Antigen Complex; D000068879:Adalimumab